Medicare Enrolled

Dr. Deborah Majchel Koss, M.D.

Endocrinology · Bradenton, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
11715 RANGELAND PKWY, Bradenton, FL 34211
9415380077
In practice since 2010 (15 years)
NPI: 1659699072 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Majchel Koss from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Majchel Koss? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Majchel Koss

Dr. Deborah Majchel Koss is an endocrinology in Bradenton, FL, with 15 years in practice. Based on federal Medicare data, Dr. Majchel Koss performed 35,728 Medicare services across 3,831 unique beneficiaries.

Between the years covered by Open Payments, Dr. Majchel Koss received a total of $3,441 from 33 pharmaceutical and/or device companies across 152 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Majchel Koss is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice▲ Top 2% volume in FL$ $3,441 industry payments

Medicare Practice Summary

Medicare Utilization ↗
35,728
Medicare services
Top 2% in FL for endocrinology
3,831
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,382 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Romosozumab injection (Evenity) for osteoporosis23,730$8$19
Denosumab injection (Prolia/Xgeva)6,360$18$42
Office visit, established patient (30-39 min)1,193$90$218
Bone density scan (DEXA)814$36$201
Blood draw (venipuncture)636$8$14
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report491$25$89
Hemoglobin A1c test (diabetes monitoring)336$9$28
Thyroid stimulating hormone (TSH) test237$16$48
Comprehensive metabolic blood panel230$10$30
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle220$55$158
Vitamin D level test161$29$81
Office visit, established patient (20-29 min)149$62$150
Basic metabolic blood panel111$8$24
Urine microalbumin test (kidney screening)111$6$14
Creatinine test (kidney function)111$5$14
Vitamin B-12 level test87$15$43
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment79$101$323
Lipid panel (cholesterol and triglycerides)76$13$38
New patient office visit (45-59 min)76$123$334
Office visit, established patient, complex (40-54 min)69$138$294
Free thyroxine (T4) test66$9$25
Fine needle aspiration biopsy using ultrasound guidance, first growth53$95$261
Calcium level, total52$5$15
Blood creatinine level52$5$15
Parathyroid hormone level test47$40$113
Complete blood count (CBC) with differential47$8$22
Fine needle aspiration biopsy using ultrasound guidance, each additional growth24$46$124
Phosphate level test21$5$14
Urinalysis with microscopic exam20$3$9
New patient office visit, complex (60-74 min)18$156$421
Magnesium level test14$7$18
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin14$46$108
Ferritin level test (iron stores)12$13$39
Prostate cancer screening; prostate specific antigen test (psa)11$19$51
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,441
Total received (2018-2024)
Avg $492/year across 7 years
Top 48% in FL for endocrinology
33
Companies
152
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,399 (98.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$41 (1.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$366
2023
$196
2022
$570
2021
$569
2020
$178
2019
$675
2018
$887

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$763
Tandem Diabetes Care, Inc.
$346
Mannkind Corporation
$327
Amgen Inc.
$261
SANOFI-AVENTIS U.S. LLC
$215
Radius Health, Inc.
$192
Medtronic MiniMed, Inc.
$161
Xeris Pharmaceuticals, Inc.
$94
Lilly USA, LLC
$91
AstraZeneca Pharmaceuticals LP
$89
Corcept Therapeutics
$75
RECORDATI_RARE_DISEASES_INC.
$74
Dexcom, Inc.
$74
BETA BIONICS, INC.
$72
GlaxoSmithKline, LLC.
$61
ABBVIE INC.
$57
Merck Sharp & Dohme Corporation
$55
MannKind Corporation
$54
Boehringer Ingelheim Pharmaceuticals, Inc.
$44
Insulet Corporation
$38
Medtronic, Inc.
$38
Shire North American Group Inc
$35
Rhythm Pharmaceuticals, Inc.
$33
Antares Pharma, Inc.
$30
Alexion Pharmaceuticals, Inc.
$27
CeQur Corporation
$26
Companion Medical, Inc.
$22
Senseonics, Incorporated
$17
Almatica Pharma LLC
$17
Amneal Pharmaceuticals LLC
$16
Abbott Laboratories
$14
Janssen Pharmaceuticals, Inc
$12
DEXCOM, INC.
$12
Top 3 companies account for 41.7% of total payments
Associated products mentioned in payments ›
AFREZZA · ANORO · BAQSIMI · BREO · CeQur Simplicity · DEXCOM CGM · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EVENITY · Eversense · FARXIGA · FREESTYLE LIBRE 3 · GVOKE PFS · InPen · JANUVIA · JARDIANCE · Korlym · MINIMED 770G · MINIMED 780G · MOUNJARO · Minimed 530G · Minimed 670G System · NATPARA · Omnipod · Otrexup · Ozempic · RYBELSUS · Rybelsus · SOLIQUA · SOLIQUA 100/33 · STEGLUJAN · STRENSIQ · SYMBICORT · SYNTHROID · Strensiq · TERIPARATIDE · TOUJEO · TRELEGY ELLIPTA · TRULICITY · Tresiba · Tymlos · UNITHROID · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $10 per 100 Medicare services performed
Looking for a endocrinology in Bradenton?
Compare endocrinologys in the Bradenton area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
25
Per 100K population
6.0
County median income
$75,792
Nearest hospital
LAKEWOOD RANCH MEDICAL CENTER
3.4 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Majchel Koss is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), and low-engagement industry engagement, with 15 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Majchel Koss experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Dr. Majchel Koss performed 23,730 romosozumab injection (evenity) for osteoporosis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Majchel Koss receive payments from pharmaceutical companies?
Yes. Dr. Majchel Koss received a total of $3,441 from 33 companies across 152 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Majchel Koss's costs compare to other endocrinologys in Bradenton?
Dr. Majchel Koss's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Majchel Koss) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →